Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Performance of Prostate HistoScanningTM (PHS) in Men at Risk of Prostate Cancer Scheduled for an Initial Prostate Biopsy

NCT01950871 is registered in ClinicalTrials.gov with Advanced Medical Diagnostics s.a. as lead sponsor.

NCT NCT01950871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01950871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Performance of Prostate HistoScanningTM (PHS) in Men at Risk of Prostate Cancer Scheduled for an Initial Prostate Biopsy
Lead sponsor
Advanced Medical Diagnostics s.a.
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2013
Completion date
July 31, 2014
Enrollment
80 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer